Inhibition of Trim8 binding site on the KSP enzyme or even blocking TRIM8 itself might be a convenient strategy to develop new and effective KSP inhibitors to treat brain cancer in TRIM8 related phenotypes [52]. This evidence concerns the gene TRIM8 and brain cancer.